Last reviewed · How we verify

NCT01907555

Clinical, Molecular and Physiopathological Study of Cohen Syndrome and Cohen-like Syndromes

Completed Last updated 31 January 2018
What this trial tests

trial in Cohen Syndrome in 100 participants. Completed in 13 September 2016.

Timeline
24 July 2013
Primary endpoint
13 September 2016
13 September 2016

Quick facts

Lead sponsorCentre Hospitalier Universitaire Dijon
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date24 July 2013
Primary completion13 September 2016
Estimated completion13 September 2016
Sites1 location across France

Conditions studied

Sponsor

Centre Hospitalier Universitaire Dijon

Who can join

Eligibility, any sex, with Cohen Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will make it possible to better understand the natural history of Cohen Syndrom and the phenotypes associated with mutations in the VPS13B gene, to improve the therapeutic management of patients. It will also provide a better description of Cohen-like syndrome for genetic counselling for the families concerned.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire Dijon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01907555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing